Cargando…

The use of FDG-PET in diffuse large B cell lymphoma (DLBCL): predicting outcome following first line therapy

Positron emission tomography (PET) using (18)fluoro-2-deoxyglucose (FDG) has become a standard clinical tool for staging and response assessment in aggressive lymphomas. The use of PET scans in clinical trials is still under exploration, however. In this review, we examine current data regarding PET...

Descripción completa

Detalles Bibliográficos
Autores principales: Coughlan, Monica, Elstrom, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264252/
https://www.ncbi.nlm.nih.gov/pubmed/25608713
http://dx.doi.org/10.1186/s40644-014-0034-9